The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm.
Amna ZafarZsofia D DrobniMatthew LeiCarlos A GongoraThiago Quinaglia A C SilvaUvette Y LouRamya MosarlaSean P MurphyMaeve Jones-O'ConnorAli MahmoodSarah HartmannHannah K GilmanColin D WeekesRyan NippJohn R ClarkJeffrey W ClarkLawrence S BlaszkowskyErica TavaresTomas G NeilanPublished in: PloS one (2022)
Re-challenge after pre-treatment with CCBs and nitrates guided by a cardio-oncology service was safe and allowed continued 5-FU therapy.
Keyphrases
- coronary artery disease
- subarachnoid hemorrhage
- mental health
- healthcare
- coronary artery
- palliative care
- heart failure
- mesenchymal stem cells
- replacement therapy
- combination therapy
- cerebral ischemia
- bone marrow
- left ventricular
- transcatheter aortic valve replacement
- blood brain barrier
- aortic valve
- smoking cessation